Protalix Biotherapeutics Inc. (PLX)
NYSE · Healthcare
Protalix Biotherapeutics Inc. annual/quarterly long term debt history from 2011 to 2014. Long term debt refers to financial obligations that are due more than one year in the future.
- Protalix Biotherapeutics Inc. long term debt for the quarter ending December 31, 2014 were 912,000, a 61.54% decrease year-over-year.
- Protalix Biotherapeutics Inc. long term debt for 2014 were 912,000, a 61.54% decrease from 2013.
- Protalix Biotherapeutics Inc. long term debt for 2013 were 2.4M, a 56.29% decrease from 2012.
- Protalix Biotherapeutics Inc. long term debt for 2012 were 5.4M, a 17.38% decrease from 2011.
- Protalix Biotherapeutics Inc. long term debt for 2011 were 6.6M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Protalix Biotherapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2014 | $1 |
| 2013 | $2 |
| 2012 | $5 |
| 2011 | $7 |
| Protalix Biotherapeutics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2014-12-31 | $1 |
| 2013-12-31 | $2 |
| 2012-12-31 | $5 |
| 2011-12-31 | $7 |
Protalix Biotherapeutics Inc. Long Term Debt — FAQ
Protalix Biotherapeutics Inc. (PLX) long term debt over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PLX's long term debt history?
The chart and table above show Protalix Biotherapeutics Inc.'s long term debt by year and by quarter, including the growth rate.